If you’d invested in: Microgen and Adgorithms
Microgen is a London-based software company with offices around the world, listed on Aim. The firm’s shares have risen by more than 80% in the last year.
Microgen (Aim: MCGN) is a London-based software company with offices around the world, listed on Aim. It develops investment-administration software for fund managers, wealth managers and private banks, and financial accounting software for other companies.
In the six months to the end of June, the company made a pre-tax profit of £3.8m, up slightly from £3.7m in the same period last year. The firm's shares have risen by more than 80% in the last year and by almost 40% in the last month.
Be glad you didn't buy...
Adgorithms (Aim: ADGO)
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Adgorithms listed on Aim in June 2015, but soon after published two profit warnings that slashed its value by over 60%. The shares have continued to fall and are down more than 85% since listing.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge